🔬 In the first issue of Insights by Servier, our digital magazine launched in March, we explore the unique advantages and challenges faced by mid-size pharmaceutical companies with Mathieu Lamiaux, Managing Director and Senior Partner at Boston Consulting Group (BCG), and Jerome Klein, Head of Corporate Strategy at Servier. 💡 Highlighting their ability to innovate by targeting smaller patient groups and less competitive markets, we look at how these companies leverage their independence and long-term vision to excel in the industry. ✅ One key opportunity is investing in underserved geographical areas where other players are not yet present. A significant challenge, however, is having to compete with the extensive R&D budgets available to big pharma. Follow this link to read the full interview 👉 https://lnkd.in/eNQwqyFC #WeAreServier #InsightsByServier #PharmaceuticalIndustry
In Pakistan Mid-size companies have a deeper understanding of the local market, enabling them to tailor products and services accordingly. and the challenge is Attracting and retaining skilled professionals can be difficult in a competitive market.
Interesting!
1st Year MBA Business Unit Manager
3moNot to mention deep rooted positive values shared by all the members of Servier family. 💙🤍🧡